I’m Katy, and the last time I wrote my story for Caring Matters Now, I was 12 years old and had just started at secondary school. Since then, I’ve danced with the English Youth Ballet, competed with my university dance teams, and worked at Camp America. More recently, I’ve worked on a cruise ship and…
Caring Matters Now have successfully secured a grant from VTCT Foundation and have teamed up with Centre for Appearance Research to create a resource to support young people with Congenital Melanocytic Naevi. This will be a freely available resource that contains important information about CMN and how to cope with common issues that young people with CMN may face.…
In conjunction with Rare Disease Day 2021, Caring Matters Now is partnering with CMN patient support groups across the world to raise global awareness of Congenital Melanocytic Naevus… and you can join in with us!
A huge THANK YOU and CONGRATULATIONS to all those who have completed a monthly challenge so far!
As a fifteen-year-old with CMN, which covers my back arms and legs, I have endured many hard times as well as amazing and inspiring experiences. Having CMN evidently makes me stand out when I don’t necessarily want to and makes people stare when (you guessed it) I don’t want people to stare. Having these special…
After much deliberation we are delighted to announce that the winner of the 2020 Jessica Ma Award is……..
As 2020 comes to an end, we all need something positive to focus our attention on for 2021, so why not sign up to our ‘Stepping up for CMN’ challenge? You will not only make 2021 a year to remember, but you will also be supporting the work of Caring Matters Now by raising vital funds to continue our work. It’s a win-win challenge for everyone!
We are thrilled to announce the establishment of Caring Matters Now Ireland. Over the past 24 months, the Caring Matters Now Board of Trustees have been working towards establishing a sister charity in Ireland.
We are thrilled to announce Veronica Kinsler has been awarded an NIHR Professorship to continue to research targeted therapies for CMN and melanoma.
